VOLORIDGE INVESTMENT MANAGEMENT, LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 220 filers reported holding TG THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.

Quarter-by-quarter ownership
VOLORIDGE INVESTMENT MANAGEMENT, LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$13,480,784
-17.0%
1,612,534
+146.7%
0.07%
-14.3%
Q2 2023$16,234,927
-11.0%
653,580
-46.1%
0.08%
-15.4%
Q1 2023$18,251,627
+30.8%
1,213,539
+2.9%
0.09%
+16.7%
Q4 2022$13,953,166
+193.0%
1,179,473
+46.6%
0.08%
+200.0%
Q3 2022$4,762,000
+26.7%
804,369
-9.0%
0.03%
+36.8%
Q2 2022$3,758,000
-64.9%
884,316
-21.4%
0.02%
-68.9%
Q1 2022$10,702,000
+23.2%
1,125,323
+146.2%
0.06%
+27.1%
Q4 2021$8,685,000
+299.3%
457,126
+993.2%
0.05%
+166.7%
Q4 2020$2,175,000
+534.1%
41,814
+20.0%
0.02%
+80.0%
Q1 2020$343,000
+36.7%
34,846
+54.4%
0.01%
+100.0%
Q4 2019$251,00022,5690.01%
Other shareholders
TG THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Jetstream Capital LLC 200,000$7,758,0005.97%
Lion Point Capital, LP 609,128$23,628,0004.08%
RA Capital Management 3,342,743$129,665,0002.08%
Ghost Tree Capital, LLC 180,000$6,982,0001.92%
Nicholas Investment Partners, LP 660,964$25,639,0001.61%
ARDSLEY ADVISORY PARTNERS LP 350,000$13,577,0001.60%
SECTORAL ASSET MANAGEMENT INC 414,949$16,096,0001.30%
Spotlight Asset Group, Inc. 75,000$2,909,0001.12%
ACT CAPITAL MANAGEMENT, LLC 55,000$2,134,0001.10%
Pier Capital, LLC 280,486$10,880,0001.09%
View complete list of TG THERAPEUTICS INC shareholders